JP Morgan Chase’s Guardant Health GH Stock Holding History

JP Morgan Chase’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,600	Closed	-$74.3K	–	7517
2024 Q1	$74.3K	Buy	+3,600	New	+$77.2K	﹤0.01%	5787
2023 Q1	–	Sell	-1,024,000	Closed	-$27.9M	–	6896
2022 Q4	$27.9M	Buy	1,024,000 +839,000	+454%	+$38.4M	﹤0.01%	1428
2022 Q3	$9.96M	Buy	185,000 +184,600	+46,150%	+$9.48M	﹤0.01%	2153
2022 Q2	$16K	Buy	+400	New	+$19.8K	﹤0.01%	5934
2019 Q4	–	Sell	-150,000	Closed	-$9.57M	–	5710
2019 Q3	$9.57M	Buy	+150,000	New	+$13.2M	﹤0.01%	2163
2019 Q2	–	Sell	-300	Closed	-$23K	–	5841
2019 Q1	$23K	Buy	+300	New	+$16.6K	﹤0.01%	5371

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

JP Morgan Chase's GH Position: Q2 2026 in Review

JP Morgan Chase increased its Guardant Health (GH) stake by 80% in Q2 2026, buying an estimated $26.6M and bringing the position to 549,088 shares worth $85.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1152.

JP Morgan Chase first reported a position in GH in Q4 2018 and has held it in 31 quarters since. The position peaked at $126M in Q3 2019. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

JP Morgan Chase held 549,088 shares of Guardant Health worth $85.3M as of Q2 2026.
JP Morgan Chase bought 244,771 Guardant Health shares in Q2 2026, an estimated $26.6M.
Guardant Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1152 holding.
JP Morgan Chase first reported a position in Guardant Health in Q4 2018 and has held it in 31 quarters since.
JP Morgan Chase's Guardant Health position peaked at $126M in Q3 2019.
598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.